Detalhe da pesquisa
1.
Palbociclib with Fulvestrant or Letrozole in Endocrine-Sensitive Patients with HR-Positive/HER2-Negative Advanced Breast Cancer: A Detailed Safety Analysis of the Randomized PARSIFAL Trial.
Oncologist
; 28(1): 23-32, 2023 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36239405
2.
Trastuzumab and pertuzumab without chemotherapy in early-stage HER2+ breast cancer: a plain language summary of the PHERGain study.
Future Oncol
; 18(33): 3677-3688, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36300423
3.
Chemotherapy de-escalation using an 18F-FDG-PET-based pathological response-adapted strategy in patients with HER2-positive early breast cancer (PHERGain): a multicentre, randomised, open-label, non-comparative, phase 2 trial.
Lancet Oncol
; 22(6): 858-871, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34019819
4.
Epithelial-Mesenchymal Transition (EMT) Induced by TGF-ß in Hepatocellular Carcinoma Cells Reprograms Lipid Metabolism.
Int J Mol Sci
; 22(11)2021 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34073989
5.
Clathrin switches transforming growth factor-ß role to pro-tumorigenic in liver cancer.
J Hepatol
; 72(1): 125-134, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31562907
6.
An olaparib window-of-opportunity trial in patients with early-stage endometrial carcinoma: POLEN study.
Gynecol Oncol
; 159(3): 721-731, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32988624
7.
Hybrid polymeric-protein nano-carriers (HPPNC) for targeted delivery of TGFß inhibitors to hepatocellular carcinoma cells.
J Mater Sci Mater Med
; 28(8): 120, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28685231
8.
A mesenchymal-like phenotype and expression of CD44 predict lack of apoptotic response to sorafenib in liver tumor cells.
Int J Cancer
; 136(4): E161-72, 2015 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25053293
9.
High density of tryptase-positive mast cells in human colorectal cancer: a poor prognostic factor related to protease-activated receptor 2 expression.
J Cell Mol Med
; 17(8): 1025-37, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23991686
10.
A single-arm study design with non-inferiority and superiority time-to-event endpoints: a tool for proof-of-concept and de-intensification strategies in breast cancer.
Front Oncol
; 13: 1048242, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37496662
11.
Trastuzumab deruxtecan in patients with central nervous system involvement from HER2-positive breast cancer: The DEBBRAH trial.
Neuro Oncol
; 25(1): 157-166, 2023 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35639825
12.
Palbociclib Rechallenge for Hormone Receptor-Positive/HER-Negative Advanced Breast Cancer: Findings from the Phase II BioPER Trial.
Clin Cancer Res
; 29(1): 67-80, 2023 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36165912
13.
Peritumoral vascular invasion and NHERF1 expression define an immunophenotype of grade 2 invasive breast cancer associated with poor prognosis.
BMC Cancer
; 12: 106, 2012 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-22439624
14.
Overexpression of nuclear NHERF1 in advanced colorectal cancer: association with hypoxic microenvironment and tumor invasive phenotype.
Exp Mol Pathol
; 92(3): 296-303, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22440733
15.
Pembrolizumab in combination with tocilizumab in high-risk hospitalized patients with COVID-19 (COPERNICO): A randomized proof-of-concept phase II study.
Int J Infect Dis
; 123: 97-103, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35987472
16.
Radium-223 for patients with metastatic castration-resistant prostate cancer with asymptomatic bone metastases progressing on first-line abiraterone acetate or enzalutamide: A single-arm phase II trial.
Eur J Cancer
; 173: 317-326, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35981452
17.
Tissue remodelling in breast cancer: human mast cell tryptase as an initiator of myofibroblast differentiation.
Histopathology
; 58(7): 1096-106, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21707711
18.
Na+/H+ exchanger regulatory factor 1 expression levels in blood and tissue predict breast tumour clinical behaviour.
Histopathology
; 58(7): 1086-95, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21707710
19.
The Impact of Excluding Nonrandomized Studies From Systematic Reviews in Rare Diseases: "The Example of Meta-Analyses Evaluating the Efficacy and Safety of Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis".
Front Mol Biosci
; 8: 690615, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34239895
20.
Surrogate endpoints for early-stage breast cancer: a review of the state of the art, controversies, and future prospects.
Ther Adv Med Oncol
; 13: 17588359211059587, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34868353